A crossover clinical study to evaluate pain intensity from microneedle insertion in different parts of the oral cavity

Stephany Di Carla Santos, Nádia Cristina Fávaro-Moreira, Henrique Ballassin Abdalla, Gabriela Gama Xavier Augusto, Yuri Martins Costa, Maria Cristina Volpato, Francisco Carlos Groppo, Harvinder Singh Gill, Michelle Franz-Montan

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


The objective of the present study was to evaluate discomfort and safety of microneedle (MN) insertion in several intraoral regions. A device was developed to standardize MN insertions. MNs were inserted in the following regions of the oral cavity: gingiva, palatine alveolar process, buccal mucosa, dorsum of the tongue and inner portion of the lower lip. Perforations from MNs post insertion were confirmed with topical gentian violet stain. Pain was evaluated in a randomized, double-blinded, crossover study in 30 volunteers. Each volunteer received a MN patch, a 30G hypodermic needle (positive control) and an identical MN patch with its needles laying flat in the plane of the patch (negative control). Adverse events were visually evaluated immediately after (0 h) and 24 h post MN application. The application device developed a consistent application force (10 N) and promoted perforation of all individual MNs on a patch. At all sites, insertion of the hypodermic needle promoted more pain when compared to the negative control (p < 0.001). Application of the MNs promoted less pain than the hypodermic needle (p < 0.05), but slightly more pain as compared to the negative control (p < 0.05) at all sites except the tongue, where the MN did not differ from the negative control (p > 0.05). Hypodermic needle caused bleeding at all insertion sites. In contrast, MNs did not cause bleeding at most sites except in some cases of insertion into the hard gingiva and the palatine alveolar process where tiny blood spots appeared immediately after MN application for few of the MNs on the patch. There were no cases of bleeding at 24 h post MN application. In conclusion, MNs can perforate different sites of the oral cavity in a safe and significantly less painful manner as compared to the 30G hypodermic needle. Thus, analogous to the skin, MN-based approaches could be an attractive approach for drug delivery in the oral cavity.

Original languageEnglish
Article number120050
JournalInternational Journal of Pharmaceutics
StatePublished - Jan 5 2021


  • Clinical trial
  • Drug delivery
  • Microneedles
  • Oral mucosa
  • Topical administration
  • Transmucosal


Dive into the research topics of 'A crossover clinical study to evaluate pain intensity from microneedle insertion in different parts of the oral cavity'. Together they form a unique fingerprint.

Cite this